Bank of New York Mellon Corp Increases Stock Position in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)
Bank of New York Mellon Corp raised its holdings in shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Free Report) by 1.2 ...
JPMorgan Chase & Co. Issues Positive Forecast for Syndax Pharmaceuticals (NASDAQ:SNDX) Stock Price
Syndax Pharmaceuticals (NASDAQ:SNDX – Free Report) had its price objective raised by JPMorgan Chase & Co. from $39.00 to $41.00 in a research note released on Thursday morning,Benzinga reports.